Financials

  • Market Capitalization 484.09 M
  • Employee 116
  • Founded 2013
  • CEO Shankar Musunuri
  • Website www.ocugen.com
  • Headquarter Delaware, United States
  • FIGI BBG00194VJB1
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.54
ratio cours/chiffre d'affaires
123.5

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2931
VSTM
Verastem, Inc. - Common Stock
5.57 USD+3.72%+16.04%+38.90%+13.21%489.46 M USD
2943
NVCT
Nuvectis Pharma, Inc. - Common Stock
18.29 USD-0.81%-3.43%+62.72%+123.32%485.15 M USD
2946
KYTX
Kyverna Therapeutics, Inc. - Common Stock
7.94 USD+2.19%-16.77%-2.58%+103.59%482.71 M USD
2948
STTK
Shattuck Labs, Inc. - Common Stock
6.29 USD-2.18%-13.24%+34.69%+706.41%482.32 M USD

Nouvelles